Tags

Type your tag names separated by a space and hit enter

Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism and productivity.
Womens Health Issues. 2010 Jan-Feb; 20(1):58-65.WH

Abstract

PURPOSE

To assess the effects of premenstrual disorders on work productivity and absenteeism in the multinational Impact study.

METHODS

Women aged 15-45 years were screened for suspected premenstrual dysphoric disorders (PMDD) and premenstrual syndrome (PMS) and invited to participate in this web-based study. Based on the Daily Record of Severity of Problems (DRSP) questionnaire, symptoms were assessed prospectively over 2 months. Participants were categorized as having no perceived symptoms/mild PMS or moderate-to-severe PMS/PMDD based on a validated algorithm. Work productivity impairment and absenteeism were assessed retrospectively using the Premenstrual Symptoms Screening Tool (PSST) and a modified version of the Work Productivity and Activity Impairment (WPAI) questionnaire. Work productivity impairment was also assessed prospectively over 2 months using the DRSP questionnaire.

RESULTS

Overall 1,477 women started the study-of these, 822 (56%) completed the study as planned and represent the full analysis set. Employed women with moderate-to-severe PMS/PMDD had higher rate of productivity impairment on the modified version of the WPAI questionnaire (values >/=7) relative to those with no perceived symptoms/mild PMS (adjusted odds ratio, 3.12; 95% confidence interval, 1.75-5.57). Similar outcomes were obtained for impairment of working productivity or efficiency using the PSST scale (value 4). The mean number of days on the DRSP with at least moderate reduction in productivity or efficiency in daily routine was higher for women with moderate-to-severe PMS/PMDD (5.6 vs. 1.1). Women with moderate-to-severe PMS/PMDD had a higher rate of absenteeism (>8hours per cycle; 14.2% vs. 6.0%).

CONCLUSION

Moderate-to-severe PMS/PMDD seems to be associated with work productivity impairment and increased absenteeism, and thus poses a potential economic burden.

Authors+Show Affiliations

Berlin Center for Epidemiology & Health Research, Invalidenstr. 115, D-10115 Berlin, Germany. heinemann@zeg-berlin.deNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Evaluation Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20123176

Citation

Heinemann, Lothar A J., et al. "Explorative Evaluation of the Impact of Severe Premenstrual Disorders On Work Absenteeism and Productivity." Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health, vol. 20, no. 1, 2010, pp. 58-65.
Heinemann LA, Minh TD, Filonenko A, et al. Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism and productivity. Womens Health Issues. 2010;20(1):58-65.
Heinemann, L. A., Minh, T. D., Filonenko, A., & Uhl-Hochgräber, K. (2010). Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism and productivity. Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health, 20(1), 58-65. https://doi.org/10.1016/j.whi.2009.09.005
Heinemann LA, et al. Explorative Evaluation of the Impact of Severe Premenstrual Disorders On Work Absenteeism and Productivity. Womens Health Issues. 2010 Jan-Feb;20(1):58-65. PubMed PMID: 20123176.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism and productivity. AU - Heinemann,Lothar A J, AU - Minh,Thai Do, AU - Filonenko,Anna, AU - Uhl-Hochgräber,Kerstin, PY - 2009/02/09/received PY - 2009/09/11/revised PY - 2009/09/29/accepted PY - 2010/2/4/entrez PY - 2010/2/4/pubmed PY - 2010/4/24/medline SP - 58 EP - 65 JF - Women's health issues : official publication of the Jacobs Institute of Women's Health JO - Womens Health Issues VL - 20 IS - 1 N2 - PURPOSE: To assess the effects of premenstrual disorders on work productivity and absenteeism in the multinational Impact study. METHODS: Women aged 15-45 years were screened for suspected premenstrual dysphoric disorders (PMDD) and premenstrual syndrome (PMS) and invited to participate in this web-based study. Based on the Daily Record of Severity of Problems (DRSP) questionnaire, symptoms were assessed prospectively over 2 months. Participants were categorized as having no perceived symptoms/mild PMS or moderate-to-severe PMS/PMDD based on a validated algorithm. Work productivity impairment and absenteeism were assessed retrospectively using the Premenstrual Symptoms Screening Tool (PSST) and a modified version of the Work Productivity and Activity Impairment (WPAI) questionnaire. Work productivity impairment was also assessed prospectively over 2 months using the DRSP questionnaire. RESULTS: Overall 1,477 women started the study-of these, 822 (56%) completed the study as planned and represent the full analysis set. Employed women with moderate-to-severe PMS/PMDD had higher rate of productivity impairment on the modified version of the WPAI questionnaire (values >/=7) relative to those with no perceived symptoms/mild PMS (adjusted odds ratio, 3.12; 95% confidence interval, 1.75-5.57). Similar outcomes were obtained for impairment of working productivity or efficiency using the PSST scale (value 4). The mean number of days on the DRSP with at least moderate reduction in productivity or efficiency in daily routine was higher for women with moderate-to-severe PMS/PMDD (5.6 vs. 1.1). Women with moderate-to-severe PMS/PMDD had a higher rate of absenteeism (>8hours per cycle; 14.2% vs. 6.0%). CONCLUSION: Moderate-to-severe PMS/PMDD seems to be associated with work productivity impairment and increased absenteeism, and thus poses a potential economic burden. SN - 1878-4321 UR - https://www.unboundmedicine.com/medline/citation/20123176/Explorative_evaluation_of_the_impact_of_severe_premenstrual_disorders_on_work_absenteeism_and_productivity_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1049-3867(09)00106-6 DB - PRIME DP - Unbound Medicine ER -